Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions 03/20/2015
RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement 02/26/2015
RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) 02/13/2015
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets 02/12/2015
RMMS Secures Reversal Before Federal Circuit, Invalidating Asserted Patents Concerning Latisse® (bimatoprost) Ophthalmic Solution 07/10/2014
U.S. Court Of Appeals For The Federal Circuit Affirms RMMS's Victory Involving Generic Ibandronate Products 04/11/2014
RMMS Secures Judgment Of Non-Infringement After A Trial Involving Generic Trizivir® (Abacavir Sulfate; Lamivudine; Zidovudine) Tablets 12/17/2013
RMMS Secures Judgment Of Patent Invalidity After A Trial Involving Gatifloxacin Ocular Formulation and Method 08/09/2013
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Mometasone Furoate Nasal Spray 06/10/2013
